Two major generic drugmakers named in this lawsuit and another, similar one could face billion-dollar fines, according to analysts at UBS.
A major antitrust lawsuit being brought by 44 US states against 20 generic drugmakers hit many of the companies' stocks hard on Monday, amid a broad-based drop in the US equity market.
Teva and Mylan, two major generic drugmakers named prominently in this lawsuit and another, similar one, could stand to lose more in the form of potential billion-dollar fines, according to new notes from analysts at UBS.alleges that the 20 drug companies worked together in a"broad conspiracy to artificially inflate and manipulate prices, reduce competition and unreasonably restrain trade for more than 100 different generic drugs.
Those drugs included treatments for cancer, HIV and more, with price increases in some cases of more than 1,000%. In addition to the companies, the suit 15 individual senior executives as defendants, including several former Teva employees and Mylan's current vice president of sales.against nearly 20 generic drugmakers, including Mylan and Teva, though the scope of that one was more limited
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
'Avengers: Endgame' tops $2 billion, bests 'Titanic' and sets sights on 'Avatar''Avengers: Endgame' is now the second-highest grossing film of all-time, earning $2.188 billion worldwide, bumping 'Titanic' out of the second spot in just 11 days.
Read more »
‘Avengers: Endgame’ blows past $2 billion and more box-office records in 2nd weekendDisney's superhero blockbuster added $145.8 million in its second weekend for a cumulative $619.7 million, becoming the fastest movie ever to get to $600 million domestically.
Read more »
A $2 Million Drug Is About to Hit the MarketA new treatment for an infant muscle-wasting disease is about to go on sale at a potential cost of $2 million, a record price tag likely to fuel the continuing scrutiny of how companies price drugs and how insurers pay for it.
Read more »
That 'Game of Thrones' mistake gave Starbucks over $2 billion in free advertisingStarbucks gained an estimated $2.3 billion in free advertising over the last few days after a modern-day coffee cup was spotted during a 'Game of Thrones' episode.
Read more »
Diamondback Energy stock surges 9% after driller launches $2 billion buyback programDiamondback Energy, a pure-play Permian Basin driller, reported solid earnings as a rare bidding war has investors focused on Permian dealmaking.
Read more »
What's The Piece-Of-The-Pie For Driverless Cars In $2 Trillion Infrastructure Plan?There is much speculation right now about a potential spend of $2 trillion on the United States infrastructure, but let's make sure that whatever happens there is consideration provided about the advent of self-driving driverless autonomous cars, for which a twofer can occur.
Read more »
The only 5 movies to ever hit $2 billion at the box office, including 'Avengers: Endgame''Avengers: Endgame' is the fifth movie to ever reach $2 billion, and it's the fastest to do so. Here are four other movies to hit this milestone.
Read more »
‘Uh-Oh, Here We Go Again’: This Week’s Trade Standoff Wipes $2 Trillion Off Global StocksAs expectations for a U.S.-China trade accord faded stocks in trade-sensitive sectors and emerging-market currencies tumbled. Meanwhile, investors braced for more choppiness ahead and piled into ultrasafe government bonds.
Read more »
VW's $2 billion penalty for diesel scam, Electrify America, builds electric chargers across USFunded by $2 billion from Volkswagen's diesel emissions settlement, Electrify America wants to have hundreds of stations and nearly 2,000 chargers in place the end of this year.
Read more »
Stocks making the biggest moves premarket: Disney, Teva Pharmaceuticals, Uber, Pinterest & moreThese are the stocks posting the largest moves before the bell.
Read more »